Bioqual Operating Income 2010-2024 | BIOQ
Bioqual operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Bioqual Annual Operating Income
(Millions of US $) |
| 2024 |
$-0 |
| 2023 |
$1 |
| 2022 |
$7 |
| 2021 |
$9 |
| 2020 |
$1 |
| 2019 |
$4 |
| 2018 |
$5 |
| 2017 |
$37 |
| 2016 |
$33 |
| 2015 |
$29 |
| 2013 |
$20 |
| 2012 |
$23 |
| 2011 |
$23 |
| 2010 |
$24 |
| 2009 |
$28 |
Bioqual Quarterly Operating Income
(Millions of US $) |
| 2024-11-30 |
$-2 |
| 2024-08-31 |
$-1 |
| 2024-05-31 |
$-2 |
| 2024-02-29 |
$0 |
| 2023-11-30 |
$1 |
| 2023-08-31 |
$1 |
| 2023-05-31 |
$-1 |
| 2023-02-28 |
$-2 |
| 2022-11-30 |
$2 |
| 2022-08-31 |
$2 |
| 2022-05-31 |
$2 |
| 2022-02-28 |
$1 |
| 2021-11-30 |
$2 |
| 2021-08-31 |
$2 |
| 2021-05-31 |
$3 |
| 2021-02-28 |
$1 |
| 2020-11-30 |
$2 |
| 2020-08-31 |
$2 |
| 2020-05-31 |
$-3 |
| 2020-02-29 |
$1 |
| 2019-11-30 |
$1 |
| 2019-08-31 |
$2 |
| 2019-05-31 |
$12 |
| 2019-02-28 |
$1 |
| 2018-11-30 |
$1 |
| 2018-08-31 |
$10 |
| 2018-05-31 |
$10 |
| 2018-02-28 |
$8 |
| 2017-11-30 |
$9 |
| 2017-08-31 |
$9 |
| 2017-05-31 |
$9 |
| 2017-02-28 |
$9 |
| 2016-11-30 |
$9 |
| 2016-08-31 |
$9 |
| 2016-05-31 |
$10 |
| 2016-02-29 |
$9 |
| 2015-11-30 |
$8 |
| 2015-08-31 |
$7 |
| 2015-05-31 |
$7 |
| 2015-02-28 |
$7 |
| 2014-08-31 |
$7 |
| 2014-05-31 |
$7 |
| 2013-11-30 |
$5 |
| 2013-08-31 |
$5 |
| 2013-05-31 |
$5 |
| 2012-05-31 |
$5 |
| 2012-02-29 |
$6 |
| 2011-11-30 |
$6 |
| 2011-08-31 |
$6 |
| 2011-05-31 |
$6 |
| 2011-02-28 |
$6 |
| 2010-11-30 |
$6 |
| 2010-08-31 |
$5 |
| 2010-05-31 |
$18 |
| 2010-02-28 |
$6 |
| 2009-11-30 |
$6 |
| 2009-08-31 |
$6 |
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.055B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
